Evidence map›Paper›PMID 39445230›Full record

ArticleWellcome open research2021

An ethical analysis of vaccinating children against COVID-19: benefits, risks, and issues of global health equity.

Rachel Gur-Arie, Steven R Kraaijeveld, Euzebiusz Jamrozik

Abstract read
In one paragraph

Article in Wellcome open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. A Scalar Approach to Vaccination Ethics.The journal of ethics · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Altruistic Vaccination: Insights from Two Focus Group Studies.Health care analysis : HCA : journal of health philosophy and policy · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rachel Gur-ArieBerman Institute of Bioethics, Johns Hopkins University, Deering Hall, 1809 Ashland Avenue, Baltimore, Maryland, 21205, USA.ORCID https://orcid.org/0000-0002-0868-7682
Steven R KraaijeveldWageningen University & Research, Hollandseweg 1, 6706 KN, Wageningen, The Netherlands.ORCID https://orcid.org/0000-0002-6338-6305
Euzebiusz JamrozikOxford-Johns Hopkins Global Infectious Disease Ethics (GLIDE) Collaborative, Oxford, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

COVID-19 vaccination of children has begun in various high-income countries with regulatory approval and general public support, but largely without careful ethical consideration. This trend is expected to extend to other COVID-19 vaccines and lower ages as clinical trials progress. This paper provides an ethical analysis of COVID-19 vaccination of healthy children. Specifically, we argue that it is currently unclear whether routine COVID-19 vaccination of healthy children is ethically justified in most contexts, given the minimal direct benefit that COVID-19 vaccination provides to children, the potential for rare risks to outweigh these benefits and undermine vaccine confidence, and substantial evidence that COVID-19 vaccination confers adequate protection to risk groups, such as older adults, without the need to vaccinate healthy children. We conclude that child COVID-19 vaccination in wealthy communities before adults in poor communities worldwide is ethically unacceptable and consider how policy deliberations might evolve in light of future developments.

Indexed as

BioethicsChild HealthCOVID-19 VaccinesEthical AnalysisHealth Equity

Identifiers

PMID39445230
PMCPMC11496933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.